Endometrial ablation for heavy menstrual bleeding

Current Opinion in Obstetrics and Gynecology

Volumn 17, Issue 4, 2005, Pages 381-394

  Munro, Malcolm G ^a  

^a KAISER FOUNDATION HOSPITAL   (United States)

Author keywords

Endometrial ablation; Heavy menstrual bleeding; Hysteroscope; Menorrhagia

Indexed keywords

LEVONORGESTREL;

AMENORRHEA; CLINICAL TRIAL; ENDOMETRIUM ABLATION; HUMAN; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; LASER SURGERY; MENSTRUATION; METRORRHAGIA; NEODYMIUM LASER; PATIENT SATISFACTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; UROLOGICAL PROCEDURES; UTERUS PERFORATION; VAGINAL HYSTERECTOMY;

EID: 22944459165     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000175356.25932.c0     Document Type: Review

References (83)

1. Goldrath MH, Fuller TA, Segal S. Laser photovaporization of endometrium for the treatment of menorrhagia. Am J Obstet Gynecol 1981; 140:14-19.
2. Vancaillie TG. Electrocoagulation of the endometrium with the ball-end resectoscope. Obstet Gynecol 1989; 74:425-427.
3. Vercellini P, Oldani S, DeGiorgi O, et al. Endometrial ablation with a vaporizing electrode in women with regular uterine cavity or submucous leiomyomas. J Am Assoc Gynecol Laparosc 1996; 3(suppl):S52.
4. Classer MH. Endometrial ablation and hysteroscopic myomectomy by electrosurgical vaporization. J Am Assoc Gynecol Laparosc 1997; 4:369-374.
5. Vercellini P, Oldani S, Yaylayan L, et al. Randomized comparison of vaporizing electrode and cutting loop for endometrial ablation. Obstet Gynecol 1999; 94:521-527.
6. DeCherney A, Polan ML. Hysteroscopic management of intrauterine lesions and intractable uterine bleeding. Obstet Gynecol 1983; 61:392-397.
7. Vercellini P, Oldani S, Milesi M, et al. Endometrial ablation with a vaporizing electrode. I. Evaluation of in vivo effects. Acta Obstet Gynecol Scand 1998; 77:683-687.
8. Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database Syst Rev 2002; CD001124.
9. Sculpher M, Thompson E, Brown J, Garry R. A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents. BJOG Int J Obstet Gynaecol 2000; 107:340-346.
10. Gannon MJ, Holt EM, Fairbank J, et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. BMJ 1991; 303:1362-1364.
11. Dwyer N, Hutton J, Stirrat GM. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. Br J Obstet Gynaecol 1993; 100:237-243.
12. Pinion SB, Parkin DE, Abramovich DR, et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ 1994; 309:979-983.
13. O'Connor H, Broadbent JA, Magos AL, McPherson K. Medical Research Council randomised trial of endometrial resection versus hysterectomy in management of menorrhagia. Lancet 1997; 349:897-901.
14. Crosignani PG, Vercellini P, Apolone G, et al. Endometrial resection versus vaginal hysterectomy for menorrhagia: long- term clinical and quality-of-life outcomes. Am J Obstet Gynecol 1997; 177:95-101.
15. Lethaby A, Hickey M. Endometrial destruction techniques for heavy menstrual bleeding: a Cochrane review. Hum Reprod 2002; 17:2795-2806.
16. Sculpher M. The cost-effectiveness of preference-based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia. Health Econ 1998; 7:129-142.
17. Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Br J Obstet Gynaecol 1999; 106:360-366.
18. Weber AM, Munro MG. Endometrial ablation versus hysterectomy: STOP-DUB. Medscape Womens Health 1998; 3:3.
19. Dickersin K, Munro M, Langenberg P, et al. Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB): design and methods. Control Clin Trials 2003; 24:591-609.
20. Bhattacharya S, Cameron IM, Parkin DE, et al. A pragmatic randomised comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia. Br J Obstet Gynaecol 1997; 104:601-607.
21. Jansen FW, Vredevoogd CB, van Ulzen K, et al. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol 2000; 96:266-270.
22. Overton C, Hargreaves J, Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Minimally Invasive Surgical Techniques-Laser, EndoThermal or Endorescetion. Br J Obstet Gynaecol 1997; 104:1351-1359.
23. Istre O, Skajaa K, Schjoensby AP, Forman A. Changes in serum electrolytes after transcervical resection of endometrium and submucous fibroids with use of glycine 1.5% for uterine irrigation. Obstet Gynecol 1992; 80:218-222.
24. Kim AH, Keltz MD, Arici A, Rosenberg M, Olive DL. Dilutional hyponatremia during hysteroscopic myomectomy with sorbitol- mannitol distention medium. J Am Assoc Gynecol Laparosc 1995; 2:237-242.
25. Taskin O, Buhur A, Birincioglu M, et al. Endometrial Na+, K+-ATPase pump function and vasopressin levels during hysteroscopic surgery in patients pretreated with GnRH agonist. J Am Assoc Gynecol Laparosc 1998; 5:119-124.
26. Isaacson K, Nardella P. Development and use of a bipolar resectoscope in endometrial electrosurgery. J Am Assoc Gynecol Laparosc 1997; 4:385-391.
27. Vilos GA. Intrauterine surgery using a new coaxial bipolar electrode in normal saline solution (Versapoint): a pilot study. Fertil Steril 1999; 72:740-743.
28. Donnez J, Vilos G, Gannon MJ, et al. Goserelin acetate (Zoladex) plus endometrial ablation for dysfunctional uterine bleeding: a large randomized, double-blind study. Fertil Steril 1997; 68:29-36.
29. Goldenberg M, Zolti M, Bider D, et al. The effect of intracervical vasopressin on the systemic absorption of glycine during hysteroscopic endometrial ablation. Obstet Gynecol 1996; 87:1025-1029.
30. Pooley AS, Ewen SP, Sutton CJ. Does transcervical resection of the endometrium for menorrhagia really avoid hysterectomy? Life table analysis of a large series. J Am Assoc Gynecol Laparosc 1998; 5:229-235.
31. Seidman DS, Bitman G, Mashiach S, et al. The effect of increasing age on the outcome of hysteroscopic endometrial resection for management of dysfunctional uterine bleeding. J Am Assoc Gynecol Laparosc 2000; 7:115-119.
32. McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum Reprod Update 1998; 4:350-359.
33. Pagedas AC, Bie IH, Perkins HE. Review of 24 cases of uterine ablation failure. J Am Assoc Gynecol Laparosc 1995; 2:539.
34. Browne DS. Endometrial resection-a comparison of techniques. Aust N Z J Obstet Gynaecol 1996; 36:448-452.
35. Eskandar MA, Vilos GA, Aletebi FA, Tummon IS. Hysteroscopic endometrial ablation is an effective alternative to hysterectomy in women with menorrhagia and large uteri. J Am Assoc Gynecol Laparosc 2000; 7:339-345.
36. Valle RF, Baggish MS. Endometrial carcinoma after endometrial ablation: high-risk factors predicting its occurrence. Am J Obstet Gynecol 1998; 179:569-572.
37. Gurtcheff SE, Sharp HT. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol 2003; 102:1278-1282.
38. Bardenheuer FH. Electrocoagulation of the uterine mucous membrane to the treatment of climacteric bleeding [in German]. Zentralbl Gynakol 1937; 4:209-211.
39. Soderstrom RM, Brooks PG, Corson SL, et al. Endometrial ablation using a distensible multielectrode balloon. J Am Assoc Gynecol Laparosc 1996; 3:403-407.
40. Corson SL, Brill AI, Brooks PG, et al. One-year results of the vesta system for endometrial ablation. J Am Assoc Gynecol Laparosc 2000; 7:489-497.
41. Cooper J, Gimpelson R, Laberge P, et al. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002; 9:418-428.
42. Gallinat A, Nugent W. NovaSure impedance-controlled system for endometrial ablation. J Am Assoc Gynecol Laparosc 2002; 9:283-289.
43. Laberge PY, Sabbah R, Fortin C, Gallinat A. Assessment and comparison of intraoperative and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems. J Am Assoc Gynecol Laparosc 2003; 10:223-232.
44. Gallinat A. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients. Am J Obstet Gynecol 2004; 191:1585-1589. Study with longest currently available follow up on the NovaSure endometrial ablation device.
45. Bongers MY, Bourdrez P, Mol BW, et al. Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG Int J Obstet Gynaecol 2004; 111:1095-1102. Generally high-quality randomized and double-blinded comparison of two NREA devices.
46. Singer A, Almanza R, Gutierrez A, et al. Preliminary clinical experience with a thermal balloon endometrial ablation method to treat menorrhagia. Obstet Gynecol 1994; 83:732-734.
47. Neuwirth RS, Duran AA, Singer A, et al. The endometrial ablator: a new instrument. Obstet Gynecol 1994; 83:792-796.
48. Friberg B, Ahlgren M. Balloon catheter endometrial thermotherapy in menorrhagia. New simple and safe alternative to hysterectomy [in Swedish]. Lakartidningen 1999; 96:4179-4181.
49. Friberg B, Ahlgren M. Thermal balloon endometrial destruction: the outcome of treatment of 117 women followed up for a maximum period of 4 years. Gynecol Endosc 2000; 9:389-395.
50. Hawe JA, Phillips AG, Chien PF, et al. Cavaterm thermal balloon ablation for the treatment of menorrhagia. Br J Obstet Gynaecol 1999; 106:1143-1148.
51. Mettler L. Long-term results in the treatment of menorrhagia and hypermenorrhea with a thermal balloon endometrial ablation technique. JSLS 2002; 6:305-309.
52. Meyer WR, Walsh BW, Grainger DA, et al. Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstet Gynecol 1998; 92:98-103.
53. Grainger DA, Tjaden BL, Rowland C, Meyer WR. Thermal balloon and rollerball ablation to treat menorrhagia: two-year results of a multicenter, prospective, randomized, clinical trial. J Am Assoc Gynecol Laparosc 2000; 7:175-179.
54. Loffer FD. Three-year comparison of thermal balloon and rollerball ablation in treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2001; 8:48-54.
55. Loffer FD, Grainger D. Five-year follow-up of patients participating in a randomized trial of uterine balloon therapy versus rollerball ablation for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002; 9:429-435.
56. Amso NN, Stabinsky SA, McFaul P, et al. Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study. International Collaborative Uterine Thermal Balloon Working Group. Br J Obstet Gynaecol 1998; 105:517-523.
57. Amso NN, Fernandez H, Vilos G, et al. Uterine endometrial thermal balloon therapy for the treatment of menorrhagia: long-term multicentre follow-up study. Hum Reprod 2003; 18:1082-1087.
58. Soysal ME, Soysal SK, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia. Gynecol Obstet Invest 2001; 51:128-133.
59. Ulmsten U, Carstensen H, Falconer C, et al. The safety and efficacy of MenoTreat, a new balloon device for thermal endometrial ablation. Acta Obstet Gynecol Scand 2001; 80:52-57.
60. Corson SL. A multicenter evaluation of endometrial ablation by Hydro ThermAblator and rollerball for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2001; 8:359-367.
61. Goldrath MH. Evaluation of HydroThermAblator and rollerball endometrial ablation for menorrhagia 3 years after treatment. J Am Assoc Gynecol Laparosc 2003; 10:505-511.
62. Glasser MH, Zimmerman JD. The HydroThermAblator system for management of menorrhagia in women with submucous myomas: 12- to 20-month follow-up. J Am Assoc Gynecol Laparosc 2003; 10:521-527.
63. Rosenbaum S, Fried M, Munro MG. Endometrial hydrothermablation: a comparison of short term clinical effectiveness with normal endometrial cavities and those with intracavitary pathology. J Min Invasive Gynecol 2005; 12:144-149.
64. Droegemueller W, Greer BE, Makowski EL. Preliminary observations of cryocoagulation of the endometrium. Am J Obstet Gynecol 1970; 107:958-961.
65. Droegemueller W, Greer B, Makowski E. Cryosurgery in patients with dysfunctional uterine bleeding. Obstet Gynecol 1971; 38:256-258.
66. Pittrof R, Majid S, Murray A. Transcervical endometrial cryoablation (ECA) for menorrhagia. Int J Gynaecol Obstet 1994; 47:135-140.
67. Rutherford TJ, Zreik TG, Troiano RN, et al. Endometrial cryoablation, a minimally invasive procedure for abnormal uterine bleeding. J Am Assoc Gynecol Laparosc 1998; 5:23-28.
68. Townsend DE, Duleba AJ, Wilkes MM. Durability of treatment effects after endometrial cryoablation versus rollerball electroablation for abnormal uterine bleeding: two-year results of a multicenter randomized trial. Am J Obstet Gynecol 2003; 188:699-701.
69. Sharp NC, Cronin N, Feldberg I, et al. Microwaves for menorrhagia: a new fast technique for endometrial ablation. Lancet 1995; 346:1003-1004.
70. Cooper KG, Bain C, Parkin DE. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial. Lancet 1999; 354:1859-1863.
71. Bain C, Cooper KG, Parkin DE. Microwave endometrial ablation versus endometrial resection: a randomized controlled trial. Obstet Gynecol 2002; 99:983-987.
72. Cooper KG, Bain C, Lawrie L, Parkin DE. A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium; follow up at a minimum of five years. BJOG Int J Obstet Gynaecol 2005; 112:470-475. A 5-7-year follow up with 90% of patients originally enrolled. This is the first study to show that a NREA device is superior to the REA device with respect to patient satisfaction and subsequent hysterectomy rates.
73. Cooper JM, Anderson TA, Fortin CA, et al. Microwave endometrial ablation vs. rollerball electroablation for menorrhagia: a multicenter randomized trial. J Am Assoc Gynecol Laparosc 2004; 11:394-403. The microwave endometrial ablation US randomized trial that resulted in approval of MEA for US distribution.
74. Soysal ME, Soysal SK, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia. Gynecol Obstet Invest 2001; 51:128-133.
75. Donnez J, Polet R, Rabinovitz R, et al. Endometrial laser intrauterine thermotherapy: the first series of 100 patients observed for 1 year. Fertil Steril 2000; 74:791-796.
76. Bhatta N, Anderson RR, Flotte T, et al. Endometrial ablation by means of photodynamic therapy with photofrin II. Am J Obstet Gynecol 1992; 167:1856-1863.
77. Van Vugt DA, Krzemien A, Roy BN, et al. Photodynamic endometrial ablation in the nonhuman primate. J Soc Gynecol Invest 2000; 7:125-130.
78. Degen AF, Gabrecht T, Mosimann L, et al. Photodynamic endometrial ablation for the treatment of dysfunctional uterine bleeding: a preliminary report. Lasers Surg Med 2004; 34:1-4.
79. Kucuk M, Okman TK. Intrauterine instillation of trichloroacetic acid is effective for the treatment of dysfunctional uterine bleeding. Fertil Steril 2005; 83:189-194. Study showing that a readily available substance may be as effective as either REA or NREA techniques and can be done in the office.
80. Abbott J, Hawe J, Hunter D, Garry R. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertil Steril 2003; 80:203-208.
81. Garside R, Stein K, Wyatt K, et al. A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG Int J Obstet Gynaecol 2004; 111:1103-1114.
82. Soysal M, Soysal S, Ozer S. A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia. Zentralbl Gynakol 2002; 124:213-219.
83. Henshaw R, Coyle C, Low S, Barry C. A retrospective cohort study comparing microwave endometrial ablation with levonorgestrel-releasing intrauterine device in the management of heavy menstrual bleeding. Aust N Z J Obstet Gynaecol 2002; 42:205-209.